CRIS - Curis Inc

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.61 -0.06 (-3.73%)	---	---	---	0.0 (0.0%)	-0.02 (-1.28%)	0.05 (3.33%)	0.05 (3.33%)

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.68
Diluted EPS:: -0.68
Basic P/E:: -2.2794
Diluted P/E:: -2.2794
RSI(14) 1m:: 100.0
VWAP:: 1.55
RVol:: 1.1126

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	1.54 -0.02 (-1.12%)	Oct 15 15:58
1m	Price decrease 1m	1.54 -0.02 (-1.28%)	Oct 15 14:10
1m	Price increase 1m	1.55 +0.03 (+1.97%)	Oct 15 12:01
10m	Price decrease 10m	1.52 -0.06 (-3.79%)	Oct 15 11:59
1m	Price decrease 1m	1.54 -0.04 (-2.53%)	Oct 15 11:51